ReCode Therapeutics

formerly Recode TX

Powering the future of genetic medicines through superior delivery

Menlo Park, United States · Founded 2020 · $390.0M raised

Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$390.0M
Last Round
$29.0M Venture RoundSep 2025
Rounds
7

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds and 11 investors for this company. The full record is or through the API.

About

ReCode is a clinical-stage genetic medicines company developing mRNA and gene correction therapies for cystic fibrosis and primary ciliary dyskinesia. Its Selective Organ Targeting lipid nanoparticle platform is designed to direct genetic medicines to organs, tissues, and cells beyond the liver. The company is advancing therapies intended to address genetically defined diseases where current treatment options are limited or absent.

Summary

ReCode Therapeutics is a Biotech company based in Menlo Park, United States, founded in 2020. It has raised $390.0M in total across 7 rounds, most recently a $29.0M Venture Round in Sep 2025. Investors include Cystic Fibrosis Foundation, Amgen and OrbiMed.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundSep 2025
$29.0M

Sign up to see all 7 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ReCode Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/recode-therapeutics"><img src="https://indexed.vc/api/badge/company/recode-therapeutics" alt="ReCode Therapeutics on Indexed.vc" width="260" height="76" /></a>